← Back to Clinical Trials
Recruiting NCT07416591

NCT07416591 Role of Saline Infusion Sonohysterography in Detection of Pelvic Adhesions in Infertile Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07416591
Status Recruiting
Phase
Sponsor Sohag University
Condition Infertile Women With Pelvic Adhesions
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-10-15
Primary Completion 2026-10-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Saline infusion sonohysterography in Detection of pelvic Adhesions in infertile women

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-10-15 with a primary completion date of 2026-10-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Infertility is agrowing concern affecting million of couples worldwide,with infertility being asignificant subset, infertility is define as inability to achieve pregnancy after one year of regular unprotected sexual intercours Among these , pelvic Adhesions present amajor challenge in reproductive medicine as they can lead to tubal occulsion and uterine cavity distortion Saline infusion sonohysterography (SIS)has emerged as minimally invasive,cost effected,and well tolerated alternative for assessing uterine and tubal abnormalities in infertile patient SIS involve the introduction of sterile saline into the uterine cavity under ultrasound guidance ,enhancing the visualization of Endometrial lining, intrauterine abnormalities and tubal patency,compared to HSG, SIS offer several advantages including the avoidance of radiation exposure, better patient comfort and the ability to stimultaneously assess the myometrium and adenxal structure

Eligibility Criteria

Inclusion Criteria: * infertile women aged 18-45yr Patient suspected to have pelvic Adhesions Women with normal ovulatory function and normal husband semen analysis Exclusion Criteria: * active pelvic infection or abnormal vaginal bleeding Pt with cervical stenosis Congenital uterine mullerian anomalies Pt with pelvic malignancy

Frequently Asked Questions

Who can join the NCT07416591 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Infertile Women With Pelvic Adhesions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07416591 currently recruiting?

Yes, NCT07416591 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sohag University to inquire about joining.

Where is the NCT07416591 trial being conducted?

This trial is being conducted at Sohag, Egypt.

Who is sponsoring the NCT07416591 clinical trial?

NCT07416591 is sponsored by Sohag University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology